| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 77.33B | 72.51B | 71.94B | 72.85B | 66.95B | 62.48B |
| Gross Profit | 23.23B | 22.46B | 21.80B | 20.62B | 19.66B | 18.48B |
| EBITDA | 13.98B | 14.33B | 9.74B | 7.38B | 6.22B | 5.26B |
| Net Income | 8.66B | 9.44B | 4.60B | 3.46B | 2.03B | 1.97B |
Balance Sheet | ||||||
| Total Assets | 133.27B | 133.34B | 101.62B | 92.81B | 87.70B | 85.77B |
| Cash, Cash Equivalents and Short-Term Investments | 11.75B | 12.65B | 8.43B | 6.86B | 6.78B | 7.00B |
| Total Debt | 15.12B | 12.22B | 6.10B | 6.18B | 5.54B | 7.45B |
| Total Liabilities | 59.10B | 57.17B | 39.13B | 37.59B | 35.71B | 34.90B |
| Stockholders Equity | 63.35B | 65.17B | 59.71B | 52.20B | 49.26B | 48.31B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.01B | -739.00M | -1.88B | 1.87B | 738.00M |
| Operating Cash Flow | 0.00 | 3.57B | 3.46B | 1.28B | 3.36B | 3.64B |
| Investing Cash Flow | 0.00 | -364.00M | -772.00M | -1.45B | -966.00M | -2.33B |
| Financing Cash Flow | 0.00 | -75.00M | -1.66B | -473.00M | -2.84B | 499.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥553.31B | 20.62 | ― | 3.26% | 11.78% | 8.98% | |
74 Outperform | ¥36.94B | 15.61 | ― | 3.70% | 14.83% | 51.42% | |
74 Outperform | ¥165.46B | 8.76 | 6.23% | 1.11% | 2.88% | 16.60% | |
69 Neutral | ¥2.38T | 13.66 | 11.64% | 1.52% | 9.81% | 32.64% | |
68 Neutral | ¥420.46B | 7.90 | 13.71% | 3.38% | 0.29% | 27.84% | |
65 Neutral | ¥357.42B | 10.69 | 8.14% | 2.61% | -1.45% | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |